Medicine
Triamcinolone acetonide 40 mg/1 mL injectable suspension
Triamcinolone acetonide 40 mg/1 mL injectable suspension is a generic prescription medicine for intra-arterial, intramuscular use, made by 2 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Do not refrigerate. Store at controlled room temperature, 20°C to 25°C (68°F…
Key facts
- Active ingredient (INN)
- Triamcinolone acetonide
- Brand
- Sold under the generic name
- Strength
- 40 mg/1 mL
- Dosage form
- Injectable suspension
- Route
- Intra-arterial, intramuscular
- Packs
- 25 vials of 1 mL, 1 mL
- Manufacturers
- Long Grove PharmaceuticalsProPharma Distribution
- Origin register
- US FDA, United States
- Storage
- Do not refrigerate. Store at controlled room temperature, 20°C to 25°C (68°F to 77°F), protect from temperatures below 20°C (68°F). Excursions are permitted between 15℃ and 30℃ (59°F and 86°F). Once in use: Chemical and physical in-use stability has been demonstrated for 28 days below 25°C (77°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- HS code (indicative)
- 3004.32Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 2 May 2022
- Identifiers
- RxCUI 1085754, 1792144DailyMed set ID 9e48eec7-7cd5-4174-8b3f-07c96f4ef115, 3edd3ad8-2561-59b5-e063-6294a90a0165NDC 81298-5781, 84549-781Application ANDA213543
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 25 vial, single-use in 1 carton / 1 mL in 1 vial, single-use | 81298-5781-5 | Long Grove Pharmaceuticals | 2 May 2022 |
| 1 mL in 1 vial, single-use | 84549-781-05 | ProPharma Distribution | 8 September 2025 |
| 1 vial, single-dose in 1 carton / 1 mL in 1 vial, single-dose | 46708-812-01 | — | 17 October 2025 |
| 25 vial, single-dose in 1 carton / 1 mL in 1 vial, single-dose | 46708-812-25 | — | 17 October 2025 |
| 1 vial, single-dose in 1 carton / 1 mL in 1 vial, single-dose | 62332-812-01 | — | 17 October 2025 |
| 25 vial, single-dose in 1 carton / 1 mL in 1 vial, single-dose | 62332-812-25 | — | 17 October 2025 |
| 1 vial, single-dose in 1 carton / 1 mL in 1 vial, single-dose | 43598-677-11 | — | 20 October 2025 |
| 25 vial, single-dose in 1 carton / 1 mL in 1 vial, single-dose | 43598-677-25 | — | 20 October 2025 |
| 1 vial in 1 carton / 1 mL in 1 vial | 70121-1049-2 | — | 11 December 2017 |
| 25 vial in 1 carton / 1 mL in 1 vial | 70121-1049-5 | — | 11 December 2017 |
| 1 vial in 1 carton / 1 mL in 1 vial | 70121-1651-1 | — | 11 December 2017 |
| 25 vial in 1 carton / 1 mL in 1 vial | 70121-1651-5 | — | 11 December 2017 |
| 1 vial in 1 carton / 1 mL in 1 vial | 70121-1657-1 | — | 11 December 2017 |
| 25 vial in 1 carton / 1 mL in 1 vial | 70121-1657-5 | — | 11 December 2017 |
| 25 vial in 1 carton / 1 mL in 1 vial | 0143-9387-25 | — | 3 March 2025 |
| 25 vial, single-dose in 1 carton / 1 mL in 1 vial, single-dose | 67457-621-99 | — | 19 August 2024 |
| 25 vial in 1 carton / 1 mL in 1 vial | 25021-054-01 | — | 1 March 2026 |
| 1 vial, single-dose in 1 carton / 1 mL in 1 vial, single-dose | 0703-0241-01 | — | 29 August 2019 |
| 1 vial in 1 carton / 1 mL in 1 vial | 16714-130-01 | — | 19 November 2019 |
| 25 vial in 1 carton / 1 mL in 1 vial | 16714-130-25 | — | 19 November 2019 |
| 1 vial, single-dose in 1 carton / 1 mL in 1 vial, single-dose | 71205-451-01 | — | 23 April 2020 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 23 October 1958 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Triamcinolone acetonide 40 mg/1 mL injectable suspension.
Other strengths and forms of Triamcinolone acetonide
Clinical summary
Triamcinolone acetonide is a corticosteroid indicated as adjunctive therapy for short-term administration (to tide the patient over an acute episode or exacerbation) in acute gouty arthritis, acute and subacute bursitis, acute nonspecific tenosynovitis, epicondylitis, rheumatoid arthritis. MedsAcross supplies Triamcinolone acetonide for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about Triamcinolone acetonideFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- KENALOG-10 prescribing information (ER Squibb & Sons) · U.S. National Library of Medicine, DailyMed
Need Triamcinolone acetonide 40 mg/1 mL injectable suspension for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.